Release Date: 29/02/12 17:35 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 162.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%